Browse by category

The global surgical staplers market is projected to reach US$7.29 Billion by 2029 from US$5.15 billion in 2024 at a compound annual...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

Adjunctive use of liraglutide at a dose of 3mg/day with conversional Roux-en-Y Gastric Bypass (cRYGB) results in significant weight loss,...

An international team of researchers has discovered a new component of the peripheral nervous system that acts by increasing energy...

A recent multi-campus study, co-led by public health researchers from University of California (UC) Irvine and UC Merced, is the first of...

Allurion Technologies has launched AllurionMeds, a unique offering to patients that combines affordable and accessible weight loss...

Researchers at Leicester Diabetes Centre (LDC) have successfully started using the glucose clamp technique as part of a new type 2...

Laekna Therapeutics has entered a clinical collaboration with Eli Lilly to accelerate the development of LAE102, a novel Activin Receptor...

More than half of US adults, an estimated that 137 million people, are eligible for semagludtide for weight loss, diabetes management, or...

Bariatric and metabolic surgery (BMS) is largely safe and effective for patients who are living with severe obesity, according to a team...